SCHEMBL740752

SCHEMBL740752

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCCCCC4)cc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.76
BCR P11274 2/20 0.76
AURKA O14965 5/20 0.53
CYP2C9 P11712 1/20 0.49
HRH3 Q9Y5N1 2/20 0.45
ACKR3 P25106 1/20 0.43
HIF1A Q16665 1/20 0.42
EPAS1 Q99814 1/20 0.42
KIT P10721 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
FLT3 P36888 1/20 0.41
KDR P35968 2/20 0.40
TNF P01375 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CDC7 O00311 1/20 0.39
CHEK1 O14757 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741183 1.00 ABL1 (0.76) ABL1BCRAURKACYP2C9HRH3
SCHEMBL742638 0.99 ABL1 (0.74) ABL1BCRAURKACYP2C9HRH3
SCHEMBL740623 0.98 ABL1 (0.72) ABL1BCRAURKACYP2C9HRH3
SCHEMBL1779493 0.95 ABL1 (0.69) ABL1BCRAURKACYP2C9HRH3
SCHEMBL1779462 0.94 ABL1 (0.68) ABL1BCRAURKACYP2C9HRH3
SCHEMBL739604 0.94 ABL1 (0.66) ABL1BCRAURKAACKR3KIT
SCHEMBL742456 0.93 ABL1 (0.65) ABL1BCRAURKACYP2C9HRH3
SCHEMBL743125 0.93 ABL1 (0.65) ABL1BCRAURKACYP2C9ACKR3
SCHEMBL740990 0.93 ABL1 (0.65) ABL1BCRAURKACYP2C9HRH3
SCHEMBL742258 0.92 ABL1 (0.65) ABL1BCRAURKAHIF1AEPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP disclosed